Aarti Pharmalabs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	64,294	67,908	39,418	24,999	-	-
Market Cap Growth	18.83%	72.28%	57.68%	-	-	-
Enterprise Value	70,486	70,778	40,892	26,947	-	-
Last Close Price	708.00	746.53	431.64	271.48	-	-
PE Ratio	30.08	24.93	18.17	12.92	-	-
PS Ratio	3.57	3.21	2.13	1.29	-	-
PB Ratio	3.14	3.41	2.24	1.60	-	-
P/TBV Ratio	3.33	3.59	2.35	1.65	-	-
P/FCF Ratio	-	-	64.89	16.89	-	-
P/OCF Ratio	-	20.48	18.22	9.99	-	-
EV/Sales Ratio	3.91	3.35	2.21	1.39	-	-
EV/EBITDA Ratio	17.21	15.59	10.75	7.88	-	-
EV/EBIT Ratio	21.93	18.75	13.07	9.64	-	-
EV/FCF Ratio	-	-	67.31	18.21	-	-
Debt / Equity Ratio	0.33	0.21	0.16	0.14	0.25	0.08
Debt / EBITDA Ratio	1.66	0.92	0.74	0.63	1.65	-
Debt / FCF Ratio	-	-	4.70	1.46	-	-
Net Debt / Equity Ratio	0.30	0.18	0.11	0.10	0.19	-1.02
Net Debt / EBITDA Ratio	1.54	0.80	0.50	0.45	1.25	-
Net Debt / FCF Ratio	-	-5.18	3.14	1.03	-1.40	-
Asset Turnover	-	0.77	0.77	0.91	1.18	-
Inventory Turnover	-	1.91	1.70	2.24	-	-
Quick Ratio	-	0.98	0.90	0.86	0.80	11.42
Current Ratio	-	2.01	1.94	1.94	1.77	11.42
Return on Equity (ROE)	-	14.54%	13.08%	13.14%	17.63%	-2.00%
Return on Assets (ROA)	-	8.60%	8.10%	8.16%	10.10%	-1.15%
Return on Invested Capital (ROIC)	9.08%	13.25%	12.34%	12.36%	15.77%	-
Return on Capital Employed (ROCE)	-	16.80%	16.60%	17.00%	11.30%	-2.00%
Earnings Yield	3.32%	4.01%	5.50%	7.74%	-	-
FCF Yield	-	-1.04%	1.54%	5.92%	-	-
Dividend Yield	0.53%	0.67%	0.69%	0.74%	-	-
Payout Ratio	-	11.64%	8.36%	9.37%	-	-
Buyback Yield / Dilution	-0.10%	-0.07%	-0.01%	-	-36150.40%	-
Total Shareholder Return	0.43%	0.60%	0.69%	0.74%	-36150.40%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.